Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs ZIM Integrated Shipping Services Ltd (ZIM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs ZIM Integrated Shipping Services Ltd — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.22 (market cap $1.74B), while ZIM Integrated Shipping Services Ltd trades at $30.27 (market cap $3.65B). The key difference: ZIM Integrated Shipping Services Ltd is far larger — about 2.1× Nuvation Bio Inc. Class A Common Stock's market cap, and ZIM Integrated Shipping Services Ltd pays a 20.16% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and ZIM Integrated Shipping Services Ltd for 27 Days on average.
| NUVB | ZIM | |
|---|---|---|
Market Cap | $1.74B | $3.65B |
Volume | 9,289,619 | 1,068,475 |
Sector | Health | Industrials |
52-Week High | $9.54 | $30.51 |
52-Week Low | $3.41 | $12.44 |
Typical Hold Time | 0 Days | 27 Days |
Enterprise Value | $1.33B | $7.32B |
Dividend Yield | — | 20.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ZIM trades at $29.99, up 2.71% with bullish technical momentum near recent highs. The stock shows mixed fundamentals with Q2 2026 earnings beating estimates but full-year profit margins declining from 6.94% to 2.15%. Valuation metrics appear attractive with P/S of 0.57 and P/B of 0.94, though analyst sentiment remains cautious with no buy ratings. Key developments include Hapag-Lloyd's $35 per share acquisition offer pending Israeli government approval.
The stock faces a strategic crossroads with acquisition uncertainty balancing against strong transpacific shipping rates. Near-term upside depends on merger approval while operational improvements support fundamental value. Primary risks include deal rejection and cyclical shipping rate volatility. Current technical strength suggests momentum may continue pending resolution of the acquisition proposal.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About ZIM Integrated Shipping Services Ltd
ZIM is a global container liner shipping company that employs a 'global-niche' strategy, focusing on specific trade lanes where it holds a competitive advantage. Unlike larger, asset-heavy competitors, ZIM operates an agile, charter-intensive fleet, allowing it to rapidly adjust capacity to market demand while prioritizing digitalization and specialized cargo like refrigerated (reefer) goods.
Read more on ZIM →
